Keyphrases
Multivariate Normal
92%
Maximum Likelihood Estimation
90%
Covariance Matrix
78%
Mean Matrix
71%
Estimation Problem
71%
Binomial Test
57%
Expected Sample Size
57%
Missing Data
57%
Prognostic Significance
57%
Leukemia
57%
Asymptotic Formula
42%
Testing Problem
42%
Covariance
42%
Auer Rods
32%
Patterned Covariance Matrices
28%
Content Determination
28%
Confidence Interval Estimation
28%
Covariance Matrix Testing
28%
Covariance Model
28%
Nested Model
28%
Normal Estimation
28%
Content Validity
28%
Mean Model
28%
Confidence Interval
28%
Fixed Sample Size
28%
Relative Efficiency
28%
Correlation Matrix
28%
Acute Leukemia
28%
Delta Method
28%
Clinical Score
28%
Likelihood Ratio
28%
Paired Data
28%
Clinical Features
28%
Diffuse Large B-cell Lymphoma (DLBCL)
28%
Trimethoprim-sulfamethoxazole (TMP-SMX)
28%
Transferase Activity
28%
Heavy Chain
28%
Terminal Deoxynucleotidyl Transferase
28%
Consolidation Chemotherapy
28%
Survival Rate
28%
Covariance Matrix Estimation
28%
Clinical Trials
28%
Binomial Sampling
28%
Asymptotic Distribution
28%
Cystic Fibrosis
28%
EM Algorithm
28%
Non-null Distribution
28%
Third Component
28%
Older Adults
28%
Prognostic Factors
28%
Mathematics
Covariance Matrix
100%
Maximum Likelihood Estimate
90%
Multivariate Normal
89%
Asymptotics
42%
Asymptotic Formula
42%
Covariance
42%
Interval Estimation
28%
Delta Method
28%
Data Pair
28%
Likelihood Ratio Statistic
28%
Confidence Interval
28%
Asymptotic Distribution
28%
Covariance Model
28%
Exact Result
28%
Correlation Matrix
28%
Nested Model
28%
Nonnull Distribution
28%
Relative Efficiency
28%
Sampling Procedure
28%
Covariance Pattern
19%
Alternative Hypothesis
14%
Asymptotic Approximation
14%
Complete Data
14%
Linear Constraint
14%
Central Limit Theorem
14%
Null
14%
Hypothesis Testing Procedure
14%
Response Data
14%
Sequential Test
9%
True State
9%
Variance
9%
Asymptotic Variance
9%
Medicine and Dentistry
Acute Myeloid Leukemia
57%
Auer Rod
32%
Receptor
28%
Metaphase
28%
DNA Nucleotidylexotransferase
28%
Scoring System
28%
Clinical Feature
28%
Heavy Chain
28%
Cystic Fibrosis
28%
B-Cell Lymphoma
28%
Survival Rate
28%
Prognostic Factor
28%
Rosette Formation
19%
Long Term Survival
14%
Proportional Hazards Model
14%
Lung Function
14%
Diseases
14%
Logistic Regression Analysis
14%
Pancreas Function
14%
Lower Respiratory Tract
14%
Staphylococcus Aureus
14%
Medical Record
14%
Clinical Trial
14%
Burkholderia cepacia
14%
Treatment of Pulmonary Infection
14%
Patient with Cystic Fibrosis
14%
Sputum
14%
Cell Surface
9%
Light Chain
9%
Cell Marker
9%
Lymphosarcoma
9%
Rosette Forming Cell
9%
Immunoglobulin Mu Chain
9%
Spontaneous Remission
9%
